Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.79691455 |
2 | modulation by symbiont of host immune response (GO:0052553) | 6.79691455 |
3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.79691455 |
4 | modulation by symbiont of host defense response (GO:0052031) | 6.79691455 |
5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.79691455 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.79691455 |
7 | response to peptidoglycan (GO:0032494) | 5.46439232 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.41925404 |
9 | neutrophil activation involved in immune response (GO:0002283) | 5.37871708 |
10 | macrophage activation involved in immune response (GO:0002281) | 5.01555699 |
11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.51186700 |
12 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.49661281 |
13 | response to host immune response (GO:0052572) | 4.49661281 |
14 | positive regulation of interferon-alpha production (GO:0032727) | 4.48630995 |
15 | regulation of interferon-alpha production (GO:0032647) | 4.30406102 |
16 | microglial cell activation (GO:0001774) | 4.29346159 |
17 | negative regulation of cell killing (GO:0031342) | 4.28257296 |
18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.28257296 |
19 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.21921315 |
20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.21784719 |
21 | immunoglobulin mediated immune response (GO:0016064) | 4.16653933 |
22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.15908166 |
23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.09225980 |
24 | response to host (GO:0075136) | 4.09225980 |
25 | response to host defenses (GO:0052200) | 4.09225980 |
26 | respiratory burst (GO:0045730) | 4.07561182 |
27 | detection of other organism (GO:0098543) | 4.07196375 |
28 | granulocyte activation (GO:0036230) | 4.02354552 |
29 | response to muramyl dipeptide (GO:0032495) | 3.97064546 |
30 | positive regulation of heat generation (GO:0031652) | 3.88172562 |
31 | neutrophil activation (GO:0042119) | 3.85950751 |
32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.84293376 |
33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.83514904 |
34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.82139620 |
35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.79806886 |
36 | myeloid cell activation involved in immune response (GO:0002275) | 3.78097308 |
37 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.75486181 |
38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.73936074 |
39 | detection of bacterium (GO:0016045) | 3.73194290 |
40 | regulation of fever generation (GO:0031620) | 3.66006885 |
41 | negative regulation of interleukin-12 production (GO:0032695) | 3.62166451 |
42 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.59660897 |
43 | negative regulation of interleukin-17 production (GO:0032700) | 3.57192643 |
44 | detection of molecule of bacterial origin (GO:0032490) | 3.56157182 |
45 | macrophage activation (GO:0042116) | 3.54171027 |
46 | detection of external biotic stimulus (GO:0098581) | 3.53502913 |
47 | superoxide anion generation (GO:0042554) | 3.52167499 |
48 | natural killer cell mediated immunity (GO:0002228) | 3.50334684 |
49 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.50334684 |
50 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.46960898 |
51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.45780603 |
52 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.45206755 |
53 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.44786654 |
54 | positive regulation of interferon-beta production (GO:0032728) | 3.42543076 |
55 | regulation of chemokine biosynthetic process (GO:0045073) | 3.42143675 |
56 | positive regulation of mast cell degranulation (GO:0043306) | 3.40438752 |
57 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.40438752 |
58 | leukocyte aggregation (GO:0070486) | 3.39839839 |
59 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.39601290 |
60 | positive regulation of antigen processing and presentation (GO:0002579) | 3.36362964 |
61 | reactive oxygen species biosynthetic process (GO:1903409) | 3.34995884 |
62 | response to protozoan (GO:0001562) | 3.34723042 |
63 | regulation of mast cell degranulation (GO:0043304) | 3.33930859 |
64 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.31284593 |
65 | B cell receptor signaling pathway (GO:0050853) | 3.31068536 |
66 | positive regulation of mast cell activation (GO:0033005) | 3.27475535 |
67 | T cell migration (GO:0072678) | 3.24418455 |
68 | cellular extravasation (GO:0045123) | 3.23940560 |
69 | positive regulation of interleukin-12 production (GO:0032735) | 3.23321975 |
70 | defense response to protozoan (GO:0042832) | 3.22813832 |
71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.22526456 |
72 | neutrophil mediated immunity (GO:0002446) | 3.22169070 |
73 | cytokine secretion (GO:0050663) | 3.21859927 |
74 | I-kappaB phosphorylation (GO:0007252) | 3.20790951 |
75 | regulation of mononuclear cell migration (GO:0071675) | 3.19305850 |
76 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.18467192 |
77 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.18194312 |
78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.16462831 |
79 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.15936260 |
80 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.15383331 |
81 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.14869692 |
82 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.12177865 |
83 | germinal center formation (GO:0002467) | 3.09187412 |
84 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.08098419 |
85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07948154 |
86 | positive regulation of B cell differentiation (GO:0045579) | 3.07718812 |
87 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.07488985 |
88 | type I interferon signaling pathway (GO:0060337) | 3.07282773 |
89 | cellular response to type I interferon (GO:0071357) | 3.07282773 |
90 | regulation of B cell differentiation (GO:0045577) | 3.07137652 |
91 | regulation of mast cell activation (GO:0033003) | 3.07120363 |
92 | leukocyte mediated cytotoxicity (GO:0001909) | 3.05110860 |
93 | response to type I interferon (GO:0034340) | 3.04800468 |
94 | positive regulation of chemokine production (GO:0032722) | 3.04638312 |
95 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.02633813 |
96 | negative regulation of T cell mediated immunity (GO:0002710) | 3.02078960 |
97 | positive regulation of type 2 immune response (GO:0002830) | 3.01715903 |
98 | myeloid dendritic cell differentiation (GO:0043011) | 3.01334427 |
99 | B cell mediated immunity (GO:0019724) | 3.00813204 |
100 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.00685338 |
101 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.00057327 |
102 | regulation of interleukin-17 production (GO:0032660) | 2.99905226 |
103 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.99735370 |
104 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.97918573 |
105 | cellular response to interferon-beta (GO:0035458) | 2.97241275 |
106 | myeloid dendritic cell activation (GO:0001773) | 2.96666040 |
107 | myeloid leukocyte activation (GO:0002274) | 2.95841508 |
108 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.95622456 |
109 | regulation of interleukin-12 production (GO:0032655) | 2.95142078 |
110 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.94340668 |
111 | regulation of leukocyte degranulation (GO:0043300) | 2.92507068 |
112 | NIK/NF-kappaB signaling (GO:0038061) | 2.91831735 |
113 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91564965 |
114 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.91104713 |
115 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.90920756 |
116 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.89942179 |
117 | eosinophil chemotaxis (GO:0048245) | 2.88616823 |
118 | regulation of heat generation (GO:0031650) | 2.87548420 |
119 | leukocyte cell-cell adhesion (GO:0007159) | 2.87519053 |
120 | regulation of antigen processing and presentation (GO:0002577) | 2.87241034 |
121 | neutrophil chemotaxis (GO:0030593) | 2.85844245 |
122 | detection of biotic stimulus (GO:0009595) | 2.85625570 |
123 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.85504668 |
124 | T-helper 1 type immune response (GO:0042088) | 2.85324619 |
125 | cellular response to exogenous dsRNA (GO:0071360) | 2.84927411 |
126 | positive regulation of macrophage cytokine production (GO:0060907) | 2.83933229 |
127 | cellular response to interferon-gamma (GO:0071346) | 2.82520784 |
128 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82417907 |
129 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.82257015 |
130 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.80329266 |
131 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.79852631 |
132 | myeloid leukocyte mediated immunity (GO:0002444) | 2.79243418 |
133 | regulation of tolerance induction (GO:0002643) | 2.79026349 |
134 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.78228929 |
135 | leukocyte degranulation (GO:0043299) | 2.77254218 |
136 | positive regulation of interleukin-10 production (GO:0032733) | 2.76911428 |
137 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.76121125 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.45028239 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.74389768 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.63011094 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.56230502 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.38808510 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.04039280 |
7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.84675424 |
8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.84168347 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.79997525 |
10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.57975325 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.49294215 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.49101562 |
13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.33295882 |
14 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.13909421 |
15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.06773828 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.00702006 |
17 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73770081 |
18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.52203571 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.32461668 |
20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.21431872 |
21 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.19186074 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18272965 |
23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.15969159 |
24 | MYC_22102868_ChIP-Seq_BL_Human | 2.07257419 |
25 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04090916 |
26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95931628 |
27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.94288580 |
28 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.87592732 |
29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.85157305 |
30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.83964047 |
31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83285771 |
32 | MYB_26560356_Chip-Seq_TH2_Human | 1.81687741 |
33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79625960 |
34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.77802654 |
35 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.72006284 |
36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68131362 |
37 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67044027 |
38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66529643 |
39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62385635 |
40 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59764297 |
41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59568512 |
42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54316503 |
43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47363501 |
44 | * MAF_26560356_Chip-Seq_TH1_Human | 1.46425098 |
45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46393803 |
46 | MYB_26560356_Chip-Seq_TH1_Human | 1.46356483 |
47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38379284 |
48 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38091955 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32816084 |
50 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32637855 |
51 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32229926 |
52 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30934859 |
53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29264317 |
54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24521763 |
55 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22566602 |
56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22136084 |
57 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20736602 |
58 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20281853 |
59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20191107 |
60 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19610028 |
61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16970114 |
62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16356160 |
63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15283810 |
64 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14258768 |
65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12546720 |
66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10671374 |
67 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08430434 |
68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08090907 |
69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06668843 |
70 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.04457320 |
71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02363457 |
72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99312167 |
73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96446786 |
74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96069567 |
75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94681212 |
76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91947933 |
77 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89255389 |
78 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86949341 |
79 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85533657 |
80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83899292 |
81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83068602 |
82 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82377285 |
83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81773634 |
84 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81198451 |
85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79854517 |
86 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78483790 |
87 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78391650 |
88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.78286487 |
89 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.77542036 |
90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76786427 |
91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76058084 |
92 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.75803185 |
93 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75737987 |
94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.75730558 |
95 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.74460802 |
96 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73806353 |
97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71545759 |
98 | MAF_26560356_Chip-Seq_TH2_Human | 0.71407443 |
99 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70060342 |
100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.67925189 |
101 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.67805104 |
102 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.67805104 |
103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67605381 |
104 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.67052986 |
105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67038054 |
106 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.66978510 |
107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65944155 |
108 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64886445 |
109 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.63708904 |
110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.62792832 |
111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62584086 |
112 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62584086 |
113 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.62571630 |
114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.60828319 |
115 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.60705839 |
116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.60496733 |
117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60332138 |
118 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59933806 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.49631964 |
2 | MP0003436_decreased_susceptibility_to | 3.89036610 |
3 | MP0009785_altered_susceptibility_to | 3.72760629 |
4 | MP0003303_peritoneal_inflammation | 3.51280473 |
5 | MP0002148_abnormal_hypersensitivity_rea | 3.50233183 |
6 | MP0002419_abnormal_innate_immunity | 3.40582513 |
7 | MP0005000_abnormal_immune_tolerance | 3.34850228 |
8 | MP0006082_CNS_inflammation | 3.23908898 |
9 | MP0003724_increased_susceptibility_to | 3.07001043 |
10 | MP0005025_abnormal_response_to | 3.04200794 |
11 | MP0005387_immune_system_phenotype | 2.86402380 |
12 | MP0001790_abnormal_immune_system | 2.86402380 |
13 | MP0002452_abnormal_antigen_presenting | 2.83256436 |
14 | MP0005058_abnormal_lysosome_morphology | 2.81117085 |
15 | MP0001800_abnormal_humoral_immune | 2.71509982 |
16 | MP0002723_abnormal_immune_serum | 2.65115199 |
17 | MP0005671_abnormal_response_to | 2.65059711 |
18 | MP0000685_abnormal_immune_system | 2.59025182 |
19 | MP0004510_myositis | 2.45428081 |
20 | MP0000569_abnormal_digit_pigmentation | 2.45251882 |
21 | MP0001819_abnormal_immune_cell | 2.37541543 |
22 | MP0002420_abnormal_adaptive_immunity | 2.35151822 |
23 | MP0003172_abnormal_lysosome_physiology | 2.21716247 |
24 | MP0009278_abnormal_bone_marrow | 2.19543272 |
25 | * MP0005464_abnormal_platelet_physiology | 2.17666023 |
26 | MP0004947_skin_inflammation | 2.11424157 |
27 | MP0001533_abnormal_skeleton_physiology | 2.07118467 |
28 | MP0001853_heart_inflammation | 1.97790369 |
29 | MP0009764_decreased_sensitivity_to | 1.93275337 |
30 | MP0002405_respiratory_system_inflammati | 1.92980717 |
31 | MP0001845_abnormal_inflammatory_respons | 1.91762504 |
32 | MP0003448_altered_tumor_morphology | 1.85709743 |
33 | MP0002006_tumorigenesis | 1.77890193 |
34 | MP0008469_abnormal_protein_level | 1.68850657 |
35 | MP0000716_abnormal_immune_system | 1.68556053 |
36 | MP0000343_altered_response_to | 1.66163239 |
37 | MP0003075_altered_response_to | 1.64200757 |
38 | MP0010155_abnormal_intestine_physiology | 1.61248501 |
39 | * MP0002398_abnormal_bone_marrow | 1.59935796 |
40 | MP0003191_abnormal_cellular_cholesterol | 1.59375626 |
41 | MP0001545_abnormal_hematopoietic_system | 1.55088470 |
42 | MP0005397_hematopoietic_system_phenotyp | 1.55088470 |
43 | MP0000858_altered_metastatic_potential | 1.47745237 |
44 | MP0009333_abnormal_splenocyte_physiolog | 1.45386773 |
45 | MP0005310_abnormal_salivary_gland | 1.43115655 |
46 | MP0005451_abnormal_body_composition | 1.42041016 |
47 | MP0003300_gastrointestinal_ulcer | 1.41672355 |
48 | MP0000689_abnormal_spleen_morphology | 1.41074410 |
49 | MP0002998_abnormal_bone_remodeling | 1.39445155 |
50 | MP0005174_abnormal_tail_pigmentation | 1.38462551 |
51 | MP0005167_abnormal_blood-brain_barrier | 1.33977732 |
52 | * MP0002429_abnormal_blood_cell | 1.33936124 |
53 | MP0003183_abnormal_peptide_metabolism | 1.29927598 |
54 | MP0009840_abnormal_foam_cell | 1.28035193 |
55 | MP0000604_amyloidosis | 1.27391880 |
56 | MP0002722_abnormal_immune_system | 1.26222514 |
57 | MP0005166_decreased_susceptibility_to | 1.24887663 |
58 | MP0003828_pulmonary_edema | 1.22176301 |
59 | MP0002166_altered_tumor_susceptibility | 1.17353513 |
60 | MP0003690_abnormal_glial_cell | 1.14181317 |
61 | MP0002254_reproductive_system_inflammat | 1.12960317 |
62 | MP0002132_abnormal_respiratory_system | 1.12561365 |
63 | MP0002933_joint_inflammation | 1.06754719 |
64 | MP0003806_abnormal_nucleotide_metabolis | 1.06719865 |
65 | MP0001851_eye_inflammation | 1.04166996 |
66 | MP0005164_abnormal_response_to | 1.02053335 |
67 | MP0009763_increased_sensitivity_to | 1.00894374 |
68 | MP0010307_abnormal_tumor_latency | 0.99457129 |
69 | MP0002277_abnormal_respiratory_mucosa | 0.98397090 |
70 | MP0005076_abnormal_cell_differentiation | 0.98115557 |
71 | MP0005390_skeleton_phenotype | 0.96818228 |
72 | MP0000371_diluted_coat_color | 0.92854659 |
73 | MP0008260_abnormal_autophagy | 0.89887415 |
74 | MP0000015_abnormal_ear_pigmentation | 0.88899794 |
75 | MP0003763_abnormal_thymus_physiology | 0.87782063 |
76 | MP0000465_gastrointestinal_hemorrhage | 0.85099770 |
77 | MP0009765_abnormal_xenobiotic_induced | 0.85038461 |
78 | MP0003566_abnormal_cell_adhesion | 0.84625355 |
79 | MP0003453_abnormal_keratinocyte_physiol | 0.84510783 |
80 | MP0000249_abnormal_blood_vessel | 0.83589305 |
81 | MP0001663_abnormal_digestive_system | 0.83314882 |
82 | MP0003656_abnormal_erythrocyte_physiolo | 0.83091637 |
83 | MP0001873_stomach_inflammation | 0.82656925 |
84 | MP0002139_abnormal_hepatobiliary_system | 0.82055728 |
85 | MP0002396_abnormal_hematopoietic_system | 0.81733478 |
86 | MP0004808_abnormal_hematopoietic_stem | 0.78856479 |
87 | MP0010352_gastrointestinal_tract_polyps | 0.77635146 |
88 | MP0004782_abnormal_surfactant_physiolog | 0.74439415 |
89 | MP0002138_abnormal_hepatobiliary_system | 0.73949108 |
90 | MP0004883_abnormal_blood_vessel | 0.69783479 |
91 | MP0003091_abnormal_cell_migration | 0.69428383 |
92 | MP0008874_decreased_physiological_sensi | 0.69195828 |
93 | MP0003186_abnormal_redox_activity | 0.67619403 |
94 | MP0005257_abnormal_intraocular_pressure | 0.65885271 |
95 | MP0000490_abnormal_crypts_of | 0.65475972 |
96 | MP0006054_spinal_hemorrhage | 0.65108557 |
97 | MP0000703_abnormal_thymus_morphology | 0.63583938 |
98 | MP0003795_abnormal_bone_structure | 0.62827815 |
99 | MP0002136_abnormal_kidney_physiology | 0.62323672 |
100 | MP0003195_calcinosis | 0.62193619 |
101 | MP0002332_abnormal_exercise_endurance | 0.59156274 |
102 | MP0000767_abnormal_smooth_muscle | 0.54966930 |
103 | MP0005165_increased_susceptibility_to | 0.54155359 |
104 | MP0008873_increased_physiological_sensi | 0.53851955 |
105 | MP0003866_abnormal_defecation | 0.53754482 |
106 | MP0002019_abnormal_tumor_incidence | 0.53053435 |
107 | MP0000920_abnormal_myelination | 0.52216743 |
108 | MP0005535_abnormal_body_temperature | 0.52037848 |
109 | MP0005023_abnormal_wound_healing | 0.50977967 |
110 | MP0000609_abnormal_liver_physiology | 0.50490196 |
111 | MP0003045_fibrosis | 0.50294505 |
112 | MP0008004_abnormal_stomach_pH | 0.49852703 |
113 | MP0002877_abnormal_melanocyte_morpholog | 0.47672634 |
114 | MP0005319_abnormal_enzyme/_coenzyme | 0.45878108 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.72025893 |
2 | Recurrent bacterial skin infections (HP:0005406) | 7.08716252 |
3 | Eczematoid dermatitis (HP:0000976) | 6.83683437 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.94806497 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.42367060 |
6 | Stomatitis (HP:0010280) | 5.27130478 |
7 | Abnormality of macrophages (HP:0004311) | 5.07746272 |
8 | Mediastinal lymphadenopathy (HP:0100721) | 5.05919548 |
9 | Optic neuritis (HP:0100653) | 4.62560473 |
10 | Retrobulbar optic neuritis (HP:0100654) | 4.62560473 |
11 | Myositis (HP:0100614) | 4.58407906 |
12 | Orchitis (HP:0100796) | 4.55068266 |
13 | Recurrent skin infections (HP:0001581) | 4.34690760 |
14 | Increased cerebral lipofuscin (HP:0011813) | 4.22730078 |
15 | Gingivitis (HP:0000230) | 4.18184788 |
16 | Systemic lupus erythematosus (HP:0002725) | 4.10548860 |
17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.09595227 |
18 | Vacuolated lymphocytes (HP:0001922) | 4.02267924 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 3.96130986 |
20 | Recurrent fungal infections (HP:0002841) | 3.94136954 |
21 | Obstructive lung disease (HP:0006536) | 3.73138429 |
22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.73138429 |
23 | Vasculitis (HP:0002633) | 3.62094207 |
24 | Prostate neoplasm (HP:0100787) | 3.45419644 |
25 | Recurrent viral infections (HP:0004429) | 3.39136696 |
26 | Interstitial pulmonary disease (HP:0006530) | 3.27246770 |
27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.26604458 |
28 | Periodontitis (HP:0000704) | 3.18800192 |
29 | Cellulitis (HP:0100658) | 3.15631881 |
30 | Pustule (HP:0200039) | 3.10133224 |
31 | Axonal loss (HP:0003447) | 3.09947385 |
32 | Pulmonary infiltrates (HP:0002113) | 3.09801712 |
33 | Thick nail (HP:0001805) | 3.07994799 |
34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.02003576 |
35 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.02003576 |
36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.00908735 |
37 | Abnormality of glycolipid metabolism (HP:0010969) | 3.00908735 |
38 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.00908735 |
39 | Disinhibition (HP:0000734) | 2.96974967 |
40 | Basal ganglia calcification (HP:0002135) | 2.91703277 |
41 | T lymphocytopenia (HP:0005403) | 2.90465035 |
42 | Leukocytosis (HP:0001974) | 2.88401829 |
43 | Chest pain (HP:0100749) | 2.87960757 |
44 | Urticaria (HP:0001025) | 2.87397433 |
45 | Meningitis (HP:0001287) | 2.83228388 |
46 | Dysostosis multiplex (HP:0000943) | 2.78460068 |
47 | Keratoconjunctivitis sicca (HP:0001097) | 2.77048667 |
48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.76618409 |
49 | Increased IgE level (HP:0003212) | 2.74321361 |
50 | Arterial thrombosis (HP:0004420) | 2.68383962 |
51 | Agammaglobulinemia (HP:0004432) | 2.67812163 |
52 | Abnormal platelet volume (HP:0011876) | 2.67482935 |
53 | Osteomyelitis (HP:0002754) | 2.65414115 |
54 | Recurrent pneumonia (HP:0006532) | 2.65029131 |
55 | Increased IgM level (HP:0003496) | 2.63294926 |
56 | Autoimmune hemolytic anemia (HP:0001890) | 2.63142031 |
57 | Hematochezia (HP:0002573) | 2.61646593 |
58 | Glomerulonephritis (HP:0000099) | 2.60801127 |
59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.58046695 |
60 | Panhypogammaglobulinemia (HP:0003139) | 2.57116938 |
61 | Gangrene (HP:0100758) | 2.56736151 |
62 | Keratoconjunctivitis (HP:0001096) | 2.52081121 |
63 | Gingival bleeding (HP:0000225) | 2.50993132 |
64 | Myocardial infarction (HP:0001658) | 2.48095904 |
65 | Abnormality of T cells (HP:0002843) | 2.47432332 |
66 | Petechiae (HP:0000967) | 2.44032037 |
67 | Increased serum ferritin (HP:0003281) | 2.42539872 |
68 | Colitis (HP:0002583) | 2.40869000 |
69 | Pulmonary embolism (HP:0002204) | 2.40815148 |
70 | Amyloidosis (HP:0011034) | 2.40781542 |
71 | Amaurosis fugax (HP:0100576) | 2.38045227 |
72 | Hemoptysis (HP:0002105) | 2.37873946 |
73 | Agnosia (HP:0010524) | 2.37443277 |
74 | Tetraparesis (HP:0002273) | 2.35961740 |
75 | Episodic fever (HP:0001954) | 2.34777815 |
76 | Granulocytopenia (HP:0001913) | 2.31435462 |
77 | Increased mean platelet volume (HP:0011877) | 2.25923923 |
78 | Recurrent lower respiratory tract infections (HP:0002783) | 2.25227038 |
79 | Osteolytic defects of the hand bones (HP:0009699) | 2.24094107 |
80 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.24094107 |
81 | Abnormality of the prostate (HP:0008775) | 2.22273118 |
82 | Premature loss of primary teeth (HP:0006323) | 2.21876816 |
83 | Chronic otitis media (HP:0000389) | 2.21199290 |
84 | Gastrointestinal infarctions (HP:0005244) | 2.20955365 |
85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19666585 |
86 | Mucopolysacchariduria (HP:0008155) | 2.19666585 |
87 | Abnormality of iron homeostasis (HP:0011031) | 2.18676430 |
88 | Impaired platelet aggregation (HP:0003540) | 2.18362517 |
89 | Abnormal platelet function (HP:0011869) | 2.18362517 |
90 | Abnormality of T cell physiology (HP:0011840) | 2.17874585 |
91 | Vertigo (HP:0002321) | 2.14579203 |
92 | Hypergammaglobulinemia (HP:0010702) | 2.14307215 |
93 | Inflammation of the large intestine (HP:0002037) | 2.13337519 |
94 | Hepatosplenomegaly (HP:0001433) | 2.12868113 |
95 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12830516 |
96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.12830516 |
97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.12830516 |
98 | Glomerulopathy (HP:0100820) | 2.12642820 |
99 | Eosinophilia (HP:0001880) | 2.12567774 |
100 | Lymphopenia (HP:0001888) | 2.12218193 |
101 | Sepsis (HP:0100806) | 2.09907048 |
102 | Bone pain (HP:0002653) | 2.09435893 |
103 | Thrombocytosis (HP:0001894) | 2.06973072 |
104 | Joint swelling (HP:0001386) | 2.06968844 |
105 | Recurrent bronchitis (HP:0002837) | 2.06783183 |
106 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05934561 |
107 | Recurrent sinusitis (HP:0011108) | 2.03008223 |
108 | Purpura (HP:0000979) | 2.00862040 |
109 | Abnormality of the peritoneum (HP:0002585) | 1.99981848 |
110 | Menorrhagia (HP:0000132) | 1.99682095 |
111 | Arthralgia (HP:0002829) | 1.98020052 |
112 | Epistaxis (HP:0000421) | 1.96150389 |
113 | Gastrointestinal inflammation (HP:0004386) | 1.93602768 |
114 | Restrictive lung disease (HP:0002091) | 1.92324507 |
115 | Prolonged bleeding time (HP:0003010) | 1.92247727 |
116 | Abnormality of T cell number (HP:0011839) | 1.92212349 |
117 | Pathologic fracture (HP:0002756) | 1.92013543 |
118 | Anorexia (HP:0002039) | 1.91413968 |
119 | Encephalitis (HP:0002383) | 1.90839274 |
120 | Loss of speech (HP:0002371) | 1.90718754 |
121 | Gastrointestinal stroma tumor (HP:0100723) | 1.90269109 |
122 | Abnormality of the pleura (HP:0002103) | 1.89946792 |
123 | Nephritis (HP:0000123) | 1.89383629 |
124 | Spontaneous hematomas (HP:0007420) | 1.88998663 |
125 | Abnormality of the pericardium (HP:0001697) | 1.88773258 |
126 | Joint hemorrhage (HP:0005261) | 1.88319230 |
127 | IgM deficiency (HP:0002850) | 1.85413520 |
128 | Progressive visual loss (HP:0000529) | 1.82596813 |
129 | Upper motor neuron abnormality (HP:0002127) | 1.82169898 |
130 | Polyneuropathy (HP:0001271) | 1.81939230 |
131 | Skin ulcer (HP:0200042) | 1.81130952 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.44902934 |
2 | RIPK4 | 4.41382890 |
3 | BLK | 3.98385810 |
4 | IRAK3 | 3.67558374 |
5 | TBK1 | 3.48314127 |
6 | MAP4K1 | 3.27056121 |
7 | IRAK4 | 3.25427909 |
8 | TXK | 2.88287153 |
9 | TYK2 | 2.84620673 |
10 | IKBKB | 2.54014266 |
11 | PRPF4B | 2.44990496 |
12 | IKBKE | 2.42200901 |
13 | JAK3 | 2.35868653 |
14 | KIT | 2.25711800 |
15 | PBK | 2.21197379 |
16 | JAK1 | 1.90275817 |
17 | MAP3K13 | 1.82384009 |
18 | ZAP70 | 1.73697229 |
19 | CSK | 1.69838715 |
20 | CSF1R | 1.67565446 |
21 | TAOK3 | 1.64666983 |
22 | TGFBR2 | 1.64628079 |
23 | CHUK | 1.61774752 |
24 | SYK | 1.58488266 |
25 | PIM2 | 1.56070468 |
26 | HCK | 1.47060883 |
27 | ERN1 | 1.46972186 |
28 | FGR | 1.37980365 |
29 | TNK2 | 1.33410410 |
30 | LYN | 1.32914555 |
31 | TESK2 | 1.32895207 |
32 | BTK | 1.30295053 |
33 | LCK | 1.23670085 |
34 | MATK | 1.21189610 |
35 | STK10 | 1.18448765 |
36 | TAOK1 | 1.17853800 |
37 | EPHB1 | 1.17352584 |
38 | RPS6KA4 | 1.13269043 |
39 | TEC | 1.13090095 |
40 | PIM1 | 1.12598036 |
41 | FES | 1.12531123 |
42 | NEK9 | 1.11771921 |
43 | BMPR2 | 1.09189967 |
44 | JAK2 | 1.07924917 |
45 | MARK3 | 1.02380930 |
46 | MST4 | 0.94972435 |
47 | GRK7 | 0.93979383 |
48 | ITK | 0.93291669 |
49 | CLK1 | 0.91212049 |
50 | EIF2AK2 | 0.86808072 |
51 | MAP2K3 | 0.86223327 |
52 | NME2 | 0.80475777 |
53 | MST1R | 0.80147718 |
54 | CDC42BPA | 0.77208379 |
55 | STK4 | 0.76110168 |
56 | BMX | 0.73512368 |
57 | PRKCD | 0.72839628 |
58 | SIK2 | 0.72336169 |
59 | CAMK1D | 0.71494543 |
60 | EGFR | 0.70004666 |
61 | SIK3 | 0.69791425 |
62 | YES1 | 0.69266718 |
63 | ABL2 | 0.67458417 |
64 | MAP3K10 | 0.66457484 |
65 | ABL1 | 0.65409051 |
66 | TRPM7 | 0.63393619 |
67 | RIPK1 | 0.60397870 |
68 | FGFR3 | 0.60234459 |
69 | MAPK12 | 0.59703312 |
70 | MAP3K5 | 0.58532434 |
71 | MAPK7 | 0.58135114 |
72 | IRAK1 | 0.57386870 |
73 | EPHA3 | 0.56770329 |
74 | MAP3K3 | 0.52467220 |
75 | TTN | 0.49849897 |
76 | KSR2 | 0.48979872 |
77 | DDR2 | 0.48095953 |
78 | MAPKAPK2 | 0.47854498 |
79 | CDK12 | 0.46419770 |
80 | LRRK2 | 0.45512589 |
81 | CAMKK2 | 0.44537786 |
82 | MAPK4 | 0.43817075 |
83 | HIPK2 | 0.42387961 |
84 | STK3 | 0.42225511 |
85 | CAMK1G | 0.41734320 |
86 | PRKCQ | 0.41116371 |
87 | IRAK2 | 0.40680536 |
88 | ADRBK2 | 0.39686050 |
89 | MAP2K6 | 0.39188107 |
90 | MOS | 0.38303900 |
91 | FYN | 0.37306384 |
92 | KDR | 0.36299492 |
93 | FGFR4 | 0.35882089 |
94 | STK24 | 0.35529459 |
95 | DAPK2 | 0.35367109 |
96 | RPS6KC1 | 0.35140392 |
97 | RPS6KL1 | 0.35140392 |
98 | MAP3K11 | 0.33947592 |
99 | PDK1 | 0.33853855 |
100 | CDK6 | 0.31829032 |
101 | PTK6 | 0.31542606 |
102 | RPS6KA6 | 0.30490690 |
103 | FLT3 | 0.30378653 |
104 | MARK2 | 0.29166770 |
105 | PDGFRB | 0.28582525 |
106 | MAP3K1 | 0.28531678 |
107 | MAPK11 | 0.28234932 |
108 | IGF1R | 0.28066882 |
109 | CDK4 | 0.27996639 |
110 | ACVR1B | 0.27745557 |
111 | GRK6 | 0.25768035 |
112 | MAP3K6 | 0.25254988 |
113 | ERBB3 | 0.24401619 |
114 | PDPK1 | 0.24073194 |
115 | INSR | 0.21777856 |
116 | MAPK3 | 0.21730570 |
117 | TAOK2 | 0.21160650 |
118 | PIK3CG | 0.20670167 |
119 | GSK3A | 0.19534865 |
120 | BMPR1B | 0.19489585 |
121 | DAPK3 | 0.19180500 |
122 | PLK2 | 0.18354904 |
123 | PTK2B | 0.18261027 |
124 | ALK | 0.17974405 |
125 | ERBB4 | 0.17746811 |
126 | PRKG2 | 0.17623940 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.54590336 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.41051038 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.12025742 |
4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.86197111 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.75354823 |
6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.66200081 |
7 | Legionellosis_Homo sapiens_hsa05134 | 2.60956991 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.54529533 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.49807505 |
10 | Pertussis_Homo sapiens_hsa05133 | 2.42570077 |
11 | Malaria_Homo sapiens_hsa05144 | 2.34491267 |
12 | Tuberculosis_Homo sapiens_hsa05152 | 2.29562920 |
13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.27830027 |
14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.26994462 |
15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.21372744 |
16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.04487889 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.03284812 |
18 | Measles_Homo sapiens_hsa05162 | 2.02392279 |
19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.93792040 |
20 | Asthma_Homo sapiens_hsa05310 | 1.84336651 |
21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.83026471 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82470228 |
23 | Lysosome_Homo sapiens_hsa04142 | 1.77884244 |
24 | Influenza A_Homo sapiens_hsa05164 | 1.77219601 |
25 | Salmonella infection_Homo sapiens_hsa05132 | 1.72159616 |
26 | Phagosome_Homo sapiens_hsa04145 | 1.68278661 |
27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.67378073 |
28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.65913619 |
29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60696330 |
30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.58707819 |
31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50654900 |
32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44283922 |
33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37814488 |
34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36670372 |
35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36666831 |
36 | Apoptosis_Homo sapiens_hsa04210 | 1.36650306 |
37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36107426 |
38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34367167 |
39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33918076 |
40 | Shigellosis_Homo sapiens_hsa05131 | 1.24095232 |
41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20744726 |
42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13589204 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.13114072 |
44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12917543 |
45 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.04560255 |
46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02991086 |
47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00103791 |
48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99488106 |
49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99030719 |
50 | Amoebiasis_Homo sapiens_hsa05146 | 0.95178783 |
51 | Hepatitis C_Homo sapiens_hsa05160 | 0.94631353 |
52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84446303 |
53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80577453 |
54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72735304 |
55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71896117 |
56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71829224 |
57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70970131 |
58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70118133 |
59 | Prion diseases_Homo sapiens_hsa05020 | 0.66987050 |
60 | Platelet activation_Homo sapiens_hsa04611 | 0.66703759 |
61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65051076 |
62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63038380 |
63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62510131 |
64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61725337 |
65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61227379 |
66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57194347 |
67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56672773 |
68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54117996 |
69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50359638 |
70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48303675 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48211539 |
72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47853159 |
73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43178821 |
74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41386082 |
75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40003916 |
76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38547362 |
77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38503701 |
78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37845368 |
79 | Bladder cancer_Homo sapiens_hsa05219 | 0.37403023 |
80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35786364 |
81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32605309 |
82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32571755 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30977501 |
84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30285407 |
85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28660005 |
86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28381129 |
87 | Endocytosis_Homo sapiens_hsa04144 | 0.27786828 |
88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26846401 |
89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26681502 |
90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25367035 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.25170100 |
92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.23578763 |
93 | Mineral absorption_Homo sapiens_hsa04978 | 0.23363719 |
94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23328202 |
95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22651706 |
96 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22328056 |
97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21262791 |
98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20664360 |
99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.19005047 |
100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16153580 |
101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.14678274 |
102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.14615880 |
103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13721609 |
104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.10834274 |
105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.10596687 |
106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09958249 |
107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.09014200 |
108 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.08991508 |
109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.08780719 |